ALQGC fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Quantum Genomics SA is a biopharmaceutical company, which engages in the development of therapies for cardiovascular diseases. It focuses on the development of drug class based on the central action mechanism of Aminopeptidase A inhibition. The company was founded by Lionel Ségard on December 23, 2005 and is headquartered in Paris, France.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
ALQGC has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company